The new service provides a safe space where teens can openly express their thoughts and feelings, develop emotional resilience, and build healthier coping skills. By addressing ...
Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...